|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.16 CNY | -2.24% |
|
-5.39% | -17.29% |
| 10/07 | China Includes Two Mayinglong Pharmaceutical Products in Essential Medicines List | MT |
| 25/05 | Mayinglong Pharmaceutical Gets Regulatory Approval for Eye Drops | MT |
| Market Cap | 9.98B 1.47B 1.29B 1.2B 1.11B 2.08B 142B 2.11B 14.3B 5.59B 69.81B 5.53B 5.42B 241B | P/E 2026 * |
14.8x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 9.98B 1.47B 1.29B 1.2B 1.11B 2.08B 142B 2.11B 14.3B 5.59B 69.81B 5.53B 5.42B 241B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 2.1x |
| Free-Float |
64.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.24% | ||
| 1 week | -5.39% | ||
| Current month | +7.12% | ||
| 1 month | +0.04% | ||
| 3 months | -7.69% | ||
| 6 months | -17.67% | ||
| Current year | -17.29% |
| 1 week | 23.07 |  | 24.2 |
| 1 month | 21.22 | | 24.69 |
| Current year | 21.22 | | 29.22 |
| 1 year | 21.22 | | 30.18 |
| 3 years | 20.2 | | 31.46 |
| 5 years | 17.99 | | 33.34 |
| 10 years | 12.52 | | 33.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
You Zhang Xia
CEO | Chief Executive Officer | 48 | 28/05/2019 |
Tao Mao
DFI | Director of Finance/CFO | 49 | 28/12/2023 |
Ping An Liu
PRN | Corporate Officer/Principal | 40 | 19/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Chen
CHM | Chairman | 64 | 16/03/2010 |
You Zhang Xia
BRD | Director/Board Member | 48 | 28/05/2019 |
Yue Zhou
BRD | Director/Board Member | 40 | 14/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.24% | -5.39% | -17.58% | -9.32% | 1.51B | |
| +0.60% | +1.21% | +48.17% | +159.82% | 1,057B | |
| +1.58% | +4.01% | +55.22% | +53.84% | 624B | |
| +0.72% | +1.67% | +35.58% | +80.70% | 454B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| +1.37% | +2.70% | +21.92% | +59.79% | 201B | |
| -0.58% | -3.29% | +14.72% | +67.22% | 162B | |
| Average | +0.28% | +0.39% | +21.56% | +45.75% | 361.55B | |
| Weighted average by Cap. | +0.68% | +1.57% | +35.58% | +77.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.32B 638M 560M 521M 478M 898M 61.41B 912M 6.19B 2.42B 30.19B 2.39B 2.34B 104B | 4.75B 702M 617M 573M 526M 989M 67.61B 1B 6.81B 2.66B 33.24B 2.64B 2.58B 115B |
| Net income | 674M 99.54M 87.43M 81.31M 74.61M 140M 9.59B 142M 965M 377M 4.71B 374M 366M 16.29B | 745M 110M 96.64M 89.87M 82.47M 155M 10.6B 157M 1.07B 417M 5.21B 413M 404M 18.01B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | CNY 23.16 | -2.24% | 4,782,447 |
| 23/07/26 | CNY 23.69 | +0.94% | 4,964,162 |
| 22/07/26 | CNY 23.47 | -0.68% | 9,027,300 |
| 21/07/26 | CNY 23.63 | -1.13% | 7,572,087 |
| 20/07/26 | CNY 23.90 | +0.89% | 9,465,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600993 Stock
Select your edition
All financial news and data tailored to specific country editions
